Cangene (FRA:YGE) Current Accrued Expense : €17.42 Mil (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene Current Accrued Expense?

Cangene's Current Accrued Expense for the quarter that ended in Oct. 2013 was €17.42 Mil.

Cangene's quarterly Current Accrued Expense declined from Apr. 2013 (€16.90 Mil) to Jul. 2013 (€15.74 Mil) but then increased from Jul. 2013 (€15.74 Mil) to Oct. 2013 (€17.42 Mil).

Cangene's annual Current Accrued Expense declined from Jul. 2011 (€12.77 Mil) to Jul. 2012 (€11.22 Mil) but then increased from Jul. 2012 (€11.22 Mil) to Jul. 2013 (€15.74 Mil).

Cangene Current Accrued Expense Historical Data

The historical data trend for Cangene's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Current Accrued Expense Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Current Accrued Expense

Get a 7-Day Free Trial

18.43

19.29

12.77

11.22

15.74

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Current Accrued Expense	Get a 7-Day Free Trial															10.92	11.98	16.90	15.74	17.42

Cangene Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Cangene Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cangene's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines